Pricing

Icosavax Inc (ICVX)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Adam K. Simpson
Employees:
30
1930 BOREN AVE., SUITE 1000, SEATTLE, WA, 98101
(206) 737-0085
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial. The company was incorporated in 2017 and is headquartered in Seattle, Washington.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available